The next-generation version of Conavi’s Novasight Hybrid system was submitted to the U.S. Food and Drug Administration (FDA) for 510 (k) clearance in September 2025. Conavi’s first-generation version ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback